All In MedTech

Company

Paragon 28

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.

Private

Total raised (reported)

$200K

2 Form D offerings, 2011 to 2013

Equity

$0

Stock sold for cash

Debt and convertible notes

$200K

$200K of it convertible

Last known valuation

Unknown

Form D filings do not report valuation

Latest round: equity, $0 raised of $6.0M sought, filed Sep 10, 2013.

Funding rounds (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Filed Sep 10, 2013Equity$0$6.0M0Rule 506Form D ↗Sep 10, 2013

1 more funding rounds with a free account

Company details

From the company's latest Form D.

Legal name
Paragon 28, Inc.
Headquarters
Englewood, Colorado
Incorporated
Colorado in 2011
Entity type
Corporation
Revenue range
$1,000,001 - $5,000,000
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    4 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    No 5%+ shareholder filings or SBIR grants found under the name Paragon 28.

    Latest FDA decisions

    The 8 newest of 60 since 2015.

    Search the Clearance Tracker

    59 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar
    • NCT05364606 · 50 participants (planned) · Start Jul 8, 2022 · Primary completion Aug 30, 2033

      Device: Patient Specific Talus Spacer · For: Avascular Necrosis of the Talus

      Sites: Santa Rosa, California; Fort Wayne, Indiana; Baltimore, Maryland · 5 sites in all

    6 more trials with a free account

    Reports received

    541

    Received Nov 1, 2025 to Nov 20, 2026

    Malfunction reports

    184

    34% of reports

    Injury reports

    357

    66% of reports

    Death reports

    0

    0.0% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 234000
    Jan 246000
    Feb 243000
    Mar 242000
    Apr 243300
    May 240300
    Jun 240000
    Jul 241000
    Aug 240200
    Sep 240000
    Oct 240000
    Nov 240000
    Dec 240000
    Jan 250000
    Feb 250000
    Mar 250100
    Apr 250000
    May 250000
    Jun 250000
    Jul 250000
    Aug 250000
    Sep 250000
    Oct 250600
    Nov 250000
    Dec 2531000
    Jan 2612100
    Feb 26151200
    Mar 26172500
    Apr 26119900
    May 26272400
    Jun 26257000
    Jul 26256600
    Aug 26202600
    Sep 26131600
    Oct 2616800
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    7 more in this ranking with a free account

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    7 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    12 more recall records with a free account

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.